ENTOCORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Entocort, and what generic alternatives are available?
Entocort is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in ENTOCORT is budesonide. There are twenty-two drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the budesonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Entocort
A generic version of ENTOCORT was approved as budesonide by TEVA PHARMS on November 18th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ENTOCORT?
- What are the global sales for ENTOCORT?
- What is Average Wholesale Price for ENTOCORT?
Summary for ENTOCORT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for ENTOCORT |
| What excipients (inactive ingredients) are in ENTOCORT? | ENTOCORT excipients list |
| DailyMed Link: | ENTOCORT at DailyMed |
US Patents and Regulatory Information for ENTOCORT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | ENTOCORT EC | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 021324-001 | Oct 2, 2001 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
